MET as resistance factor for afatinib therapy and motility...

PLoS ONE 2019 / 9 Vol. 14; Iss. 9

MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells

Ebert, Karolin, Mattes, Julian, Kunzke, Thomas, Zwingenberger, Gwen, Luber, Birgit, Sethi, Gautam
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0223225
Date:
September, 2019
File:
PDF, 3.37 MB
english, 2019
Conversion to is in progress
Conversion to is failed